Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Medicinske Tidsskrifter ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9% 1.5%   Bankruptcy risk   35.6% 6.4% 4.0% 1.3% 1.1% 3.9% 11.0% 13.0%   Credit score (0-100)   1 38 49 78 84 49 22 18   Credit rating   C BBB BBB A A BBB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 220.7 634.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,126 8,447 11,299 17,224 18,419 16,913 0.0 0.0   EBITDA   -1,342 899 999 1,802 232 -3,233 0.0 0.0   EBIT   -1,345 896 997 1,795 225 -3,239 0.0 0.0   Pre-tax profit (PTP)   -1,344.8 895.9 989.0 1,760.5 125.3 -3,250.8 0.0 0.0   Net earnings   -1,049.0 697.2 772.3 1,370.1 92.7 -3,251.1 0.0 0.0   Pre-tax profit without non-rec. items   -1,345 896 989 1,760 125 -3,251 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   9.9 7.4 4.9 18.5 12.0 5.5 0.0 0.0   Shareholders equity total   -852 -154 618 8,762 8,555 5,304 -1,746 -1,746   Interest-bearing liabilities   0.0 0.0 0.0 0.0 100 0.0 2,876 2,876   Balance sheet total (assets)   1,256 2,335 4,704 15,455 12,192 9,670 1,130 1,130   Net Debt   -442 -1,340 -1,935 -11,495 -6,971 -1,465 2,876 2,876     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,126 8,447 11,299 17,224 18,419 16,913 0.0 0.0   Gross profit growth   -11.2% 64.8% 33.8% 52.4% 6.9% -8.2% -100.0% 0.0%   Employees   0 0 0 0 0 20 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,256 2,335 4,704 15,455 12,192 9,670 1,130 1,130   Balance sheet change%   -10.7% 85.9% 101.4% 228.6% -21.1% -20.7% -88.3% 0.0%   Added value   -1,342.4 898.6 999.3 1,801.6 231.7 -3,232.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -5 -5 -5 7 -13 1,117 -6 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -26.2% 10.6% 8.8% 10.4% 1.2% -19.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -76.6% 39.0% 27.7% 17.8% 1.6% -29.6% 0.0% 0.0%   ROI %   -1,361.3% 1,317,813.2% 322.6% 38.3% 2.6% -46.4% 0.0% 0.0%   ROE %   -144.3% 38.8% 52.3% 29.2% 1.1% -46.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -44.2% -9.6% 14.6% 63.5% 73.1% 60.5% -60.7% -60.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   33.0% -149.2% -193.6% -638.1% -3,009.0% 45.3% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 1.2% 0.0% -164.7% -164.7%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 199.8% 22.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 1.4 1.3 3.1 3.8 2.4 0.0 0.0   Current Ratio   0.6 0.9 1.1 2.3 3.3 1.9 0.0 0.0   Cash and cash equivalent   442.4 1,340.3 1,934.5 11,495.0 7,070.9 1,464.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -882.3 -182.7 584.8 8,716.1 8,371.6 3,996.9 -1,438.2 -1,438.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 -162 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -162 0 0   EBIT / employee   0 0 0 0 0 -162 0 0   Net earnings / employee   0 0 0 0 0 -163 0 0